
🩸 a podcast about heme/onc for health care providers | ☕️ short high yield episodes to supplement your board review resources | @SamArmstrongMD @DrKarineTawagi
Joined June 2022
- Tweets632
- Following1.8K
- Followers4.7K
- Likes1.9K
Pinned Tweet
🤔 Heading to #ASH26?
⭐️ Join us for a complimentary in-person Hematology Board Review for fellows & anyone prepping for boards 🩸
📅 Friday, December 11, 2026
🕗 8:00 AM–12:00 PM CT
📍 420 Julia St., New Orleans, LA
🔗 Register: bit.ly/hemeboards
🤖 Made with AI
GOOD LUCK to all taking heme & onc boards this week!
We are back with localized #prostatecancer updates 💙
A 60M has unfavorable intermediate prostate cancer, and decides to undergo radiation ☢️ , what is the recommended course of ADT?
2%None
54%4-6mo ADT
20%12mo ADT
24%24mo ADT
41 votes • 9 hours TwoOncDocs retweeted
📣 FDA approval today for peri-op Durva/EV for cis-ineligible/declining + Durva only in adjuvant setting, very timely as we discuss MIBC regimens at #UromigosLIVE @Uromigost @OncoAlert
Met EFS & OS
⁉️ can we use ctDNA/pCR to de-escalate adjuvant EV?
Join us & @OncBrothers Dec 11 in New Orleans 8AM-12PM for a complimentary high yield interactive board review session on malignant & classical heme topics right before #ASHapalooza
Followed by a special career panel with our friend @rmistry91 from the @thefellowoncall🩸#ASH26
We released our cheat sheet of highest yield topics last week for ABIM exams coming up Nov 17&18!
🫁 Onc:
GI 13.5%
Breast 13.5%
GU 12%
Thoracic 11.5%
Together, represent over 50%
🩸 Heme:
Neoplasms make up 35%
Prioritize leukemias, lymphomas, and plasma cell disorders
GL! 🙏🏼
TwoOncDocs retweeted
📣 another FDA approval in APMS
➡️ MANY in 2026 inc. pluvicto & capivasertib
➡️ now talazoparib/enza vs enza #TALAPRO3 for HRR-altered APMS (vs AMPLITUDE only BRCA2)
➡️ rPFS 77% vs 56% (HR 0.48)
⚠️ OS immature, G≥3 anemia 51%, 40% transfused; no docetaxel-triplet comparator
TwoOncDocs retweeted
Incredible to see work on the very rare RCC subtypes: collecting duct & renal medullary CA at #ESMO26
#REPRINT trial testing EV + P
🎯 22% ORR & 55% DCR overall ➡️ moving to stage 2!
Also very impt trials from @PavlosMsaouel in RMC on: ubamatamab, Sac-TMT, panitumumab…
TwoOncDocs retweeted
Gorgeous AM in Retiro Park ahead of exciting RCC updates #ESMO26:
🌟final KN564 @DrChoueiri
🌟PROs of RAMPART
🌟CA-IX PET
🌟cabo/atezo in metastatic papillary RCC @maughanonc
🌟EVP in RMC
🌟LACO-Stim CART
🌟KIM-1 @VincentWenxinXu
🌟PDL1 #CARE1
🌟LITESPARK011 QoL @DrDanielHeng
TwoOncDocs retweeted
Incredible cancer breakthrough #ESMO26 w/ new benchmark in melanoma & huge advances for all future personalized tx that could extend to other cancers
🌟 Ph3 Intismeran autogene mRNA vaccine improved RFS by 42% w/ Pembro vs Pembro alone, distant mets reduced by 38%, similar AEs
TwoOncDocs retweeted
🔥 full house before #ESMO26 Presidential:
🔹#INTerpath001: Intismeran autogene + pembro vs pembro in resected melanoma
🔹#VOLGA: Periop durva ± treme + EV in MIBC
🔹#DeLLphi-305: Tarlatamab + durva vs durva as 1L maintenance in ES-SCLC
🔹Daro + ADT + RT in very high-risk PCa
TwoOncDocs retweeted
Excited to join the Clinicals to Exam – Oncology Board Review during #ASH2026 in New Orleans on December 11!
Looking forward to strengthening my clinical knowledge, gaining valuable insights, and connecting with fellow hematology/oncology professionals!
#HemeOnc #Oncology #MedEd @OncUpdates @OncBrothers @TwoOncDocs #hematology
OncologyBrothers.regfox.com/…
We are back this week with our final #breastcancer series on metastatic breast cancer 🩷
A 62yo F presents with newly diagnosed ER-positive, HER2-negative metastatic breast cancer with asymptomatic bone and nodal disease.
Which of the following is a preferred tx?
4%Letrozole alone
2%Paclitaxel
92%Aromatase inh+ ribociclib
2%Fulvestrant
53 votes • Final results TwoOncDocs retweeted
🤩 #HemOnc Fellows, are you going to #ASH26? Join for a FREE board review!
👀 Here is a sneak peek of your board review day!
🗓️ In-person w/@OncBrothers + @TwoOncDocs
🔗 Register: bit.ly/hemeboards
#OncTwitter #MedX #MedTwitter #ASH @HemOncFellows @hemeoncfellow
TwoOncDocs retweeted
🤔Headed to #ASH26? Join for a FREE board review!
🗓️ In-person w/@OncBrothers + @TwoOncDocs
📅 Friday, Dec 11th
📍 Common House,New Orleans
🔗 Register: bit.ly/hemeboards
#OncTwitter #HemOnc #MedX #MedTwitter #ASH #MedEd @HemOncFellows @hemeoncfellow @ASH_hematology
TwoOncDocs retweeted
Highly recommended! 💕 2026 update focusing on metastatic breast cancer @TwoOncDocs There is no better way to learn new Oncology meds other than treat them like new songs (listen frequently) 🎶 Learn from the BEST on proper pronunciations of Onc meds. podcasts.apple.com/us/podcas…
Today part 2 of our breast cancer series is out on Localized #BreastCancer 🩷
A 39yo woman with pt1c (1.5cm) ER+ breast cancer undergoes a lumpectomy with SLNB.
Which of the following adjuvant endocrine therapies is preferred in PRE menopausal women?
0%Anastrozole alone
4%Letrozole alone
96%Tamoxifen +/- OFS
0%Fulvestrant alone
26 votes • Final results 2
1
601
We are back with 2026 Breast Cancer updates! 🩷
In today’s episode, we cover an introduction on breast cancer, screening, prevention, DCIS, LCIS & more.
At what age range, should patients with triple negative breast cancer have genetic testing?
35%30-45yo
0%45-60yo
0%60+yo
65%All patients with TNBC
26 votes • Final results
























